25 XP   0   0   10

Actinogen Medical Ltd
Buy, Hold or Sell?

Let's analyse Actinogen together

PenkeI guess you are interested in Actinogen Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Actinogen Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Actinogen Medical Ltd

I send you an email if I find something interesting about Actinogen Medical Ltd.

Quick analysis of Actinogen (30 sec.)










What can you expect buying and holding a share of Actinogen? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.00
How sure are you?
23.1%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-8.1%

For what price can you sell your share?

Current Price per Share
A$0.03
Expected price per share
A$0.027 - A$0.056
How sure are you?
50%

1. Valuation of Actinogen (5 min.)




Live pricePrice per Share (EOD)

A$0.03

Intrinsic Value Per Share

A$-0.18 - A$-0.07

Total Value Per Share

A$-0.18 - A$-0.06

2. Growth of Actinogen (5 min.)




Is Actinogen growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7m$12.2m-$3.8m-46.3%

How much money is Actinogen making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$2.6m-$858.8k-24.2%
Net Profit Margin-56.9%-395.8%--

How much money comes from the company's main activities?

3. Financial Health of Actinogen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#693 / 1011

Most Revenue
#392 / 1011

Most Profit
#480 / 1011

Most Efficient
#644 / 1011

What can you expect buying and holding a share of Actinogen? (5 min.)

Welcome investor! Actinogen's management wants to use your money to grow the business. In return you get a share of Actinogen.

What can you expect buying and holding a share of Actinogen?

First you should know what it really means to hold a share of Actinogen. And how you can make/lose money.

Speculation

The Price per Share of Actinogen is A$0.029. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Actinogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Actinogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Actinogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-11.0%0.00-5.3%0.00-3.6%0.00-2.5%0.00-2.0%
Usd Book Value Change Per Share0.00-1.4%0.00-1.3%0.00-2.0%0.00-0.3%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1.4%0.00-1.3%0.00-2.0%0.00-0.3%0.000.3%
Usd Price Per Share0.01-0.03-0.06-0.04-0.04-
Price to Earnings Ratio-1.11--10.67--17.61--20.28--35.56-
Price-to-Total Gains Ratio-35.83--47.59--2,108.22--997,776.70--485,233.73-
Price to Book Ratio4.27-7.67-10.98-8.30-11.96-
Price-to-Total Gains Ratio-35.83--47.59--2,108.22--997,776.70--485,233.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0187108
Number of shares53445
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (53445 shares)-20.23-4.86
Gains per Year (53445 shares)-80.90-19.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-81-910-19-29
20-162-1720-39-48
30-243-2530-58-67
40-324-3340-78-86
50-405-4150-97-105
60-485-4960-117-124
70-566-5770-136-143
80-647-6580-156-162
90-728-7390-175-181
100-809-8200-194-200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%0.064.02.00.0%
Book Value Change Per Share0.02.01.00.0%2.05.04.018.2%3.09.07.015.8%9.017.013.023.1%17.029.020.025.8%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.066.00.0%
Total Gains per Share0.02.01.00.0%2.05.04.018.2%3.09.07.015.8%9.017.013.023.1%17.029.020.025.8%

Fundamentals of Actinogen

About Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-04-19 01:02:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Actinogen Medical Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Actinogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Actinogen Medical Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-56.9%+56.9%
TTM-56.9%YOY-395.8%+339.0%
TTM-56.9%5Y-5,296.8%+5,239.9%
5Y-5,296.8%10Y-4,055.3%-1,241.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.1%+196.1%
TTM-56.9%-211.9%+155.0%
YOY-395.8%-277.7%-118.1%
5Y-5,296.8%-432.9%-4,863.9%
10Y-4,055.3%-599.3%-3,456.0%
1.1.2. Return on Assets

Shows how efficient Actinogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • -81.6% Return on Assets means that Actinogen generated $-0.82 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Actinogen Medical Ltd:

  • The MRQ is -81.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -38.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-81.6%TTM-38.1%-43.5%
TTM-38.1%YOY-21.6%-16.5%
TTM-38.1%5Y-18.7%-19.4%
5Y-18.7%10Y-14.0%-4.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-81.6%-13.3%-68.3%
TTM-38.1%-12.7%-25.4%
YOY-21.6%-11.8%-9.8%
5Y-18.7%-14.0%-4.7%
10Y-14.0%-15.9%+1.9%
1.1.3. Return on Equity

Shows how efficient Actinogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • -96.5% Return on Equity means Actinogen generated $-0.96 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Actinogen Medical Ltd:

  • The MRQ is -96.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -44.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.5%TTM-44.1%-52.4%
TTM-44.1%YOY-23.3%-20.8%
TTM-44.1%5Y-20.5%-23.6%
5Y-20.5%10Y-15.3%-5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.5%-16.9%-79.6%
TTM-44.1%-16.0%-28.1%
YOY-23.3%-15.1%-8.2%
5Y-20.5%-19.7%-0.8%
10Y-15.3%-20.5%+5.2%

1.2. Operating Efficiency of Actinogen Medical Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Actinogen is operating .

  • Measures how much profit Actinogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Actinogen Medical Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-93.5%+93.5%
TTM-93.5%YOY-448.1%+354.7%
TTM-93.5%5Y-4,125.8%+4,032.3%
5Y-4,125.8%10Y-3,777.6%-348.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--290.9%+290.9%
TTM-93.5%-224.4%+130.9%
YOY-448.1%-288.3%-159.8%
5Y-4,125.8%-479.5%-3,646.3%
10Y-3,777.6%-625.2%-3,152.4%
1.2.2. Operating Ratio

Measures how efficient Actinogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.271-1.271
TTM1.271YOY4.752-3.481
TTM1.2715Y3.292-2.021
5Y3.29210Y9.802-6.510
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.110-3.110
TTM1.2713.266-1.995
YOY4.7523.783+0.969
5Y3.2925.657-2.365
10Y9.8027.783+2.019

1.3. Liquidity of Actinogen Medical Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Actinogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.42 means the company has $5.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 5.423. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.503. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.423TTM6.503-1.080
TTM6.503YOY11.325-4.822
TTM6.5035Y14.337-7.835
5Y14.33710Y11.386+2.952
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4233.905+1.518
TTM6.5034.212+2.291
YOY11.3255.337+5.988
5Y14.3376.062+8.275
10Y11.3866.401+4.985
1.3.2. Quick Ratio

Measures if Actinogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Quick Ratio of 5.40 means the company can pay off $5.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 5.403. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.457. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.403TTM6.457-1.055
TTM6.457YOY11.292-4.835
TTM6.4575Y9.641-3.184
5Y9.64110Y8.796+0.846
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4033.572+1.831
TTM6.4574.001+2.456
YOY11.2925.364+5.928
5Y9.6416.009+3.632
10Y8.7966.287+2.509

1.4. Solvency of Actinogen Medical Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Actinogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Actinogen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Actinogen assets are financed with 15.4% credit (debt) and the remaining percentage (100% - 15.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 0.154. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.130. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.130+0.024
TTM0.130YOY0.082+0.048
TTM0.1305Y0.079+0.052
5Y0.07910Y0.065+0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1540.336-0.182
TTM0.1300.334-0.204
YOY0.0820.271-0.189
5Y0.0790.366-0.287
10Y0.0650.389-0.324
1.4.2. Debt to Equity Ratio

Measures if Actinogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 18.2% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 0.182. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.146. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.146+0.037
TTM0.146YOY0.088+0.058
TTM0.1465Y0.086+0.060
5Y0.08610Y0.071+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.382-0.200
TTM0.1460.397-0.251
YOY0.0880.341-0.253
5Y0.0860.432-0.346
10Y0.0710.465-0.394

2. Market Valuation of Actinogen Medical Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Actinogen generates.

  • Above 15 is considered overpriced but always compare Actinogen to the Biotechnology industry mean.
  • A PE ratio of -1.11 means the investor is paying $-1.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Actinogen Medical Ltd:

  • The EOD is -1.460. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.107. Based on the earnings, the company is expensive. -2
  • The TTM is -10.669. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.460MRQ-1.107-0.352
MRQ-1.107TTM-10.669+9.561
TTM-10.669YOY-17.614+6.945
TTM-10.6695Y-20.282+9.613
5Y-20.28210Y-35.559+15.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.460-2.262+0.802
MRQ-1.107-2.599+1.492
TTM-10.669-2.674-7.995
YOY-17.614-4.133-13.481
5Y-20.282-6.258-14.024
10Y-35.559-6.171-29.388
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Actinogen Medical Ltd:

  • The EOD is -2.598. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.971. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.285. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.598MRQ-1.971-0.627
MRQ-1.971TTM-6.285+4.314
TTM-6.285YOY-21.524+15.239
TTM-6.2855Y-577.509+571.224
5Y-577.50910Y-312.825-264.684
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.598-2.913+0.315
MRQ-1.971-3.275+1.304
TTM-6.285-3.508-2.777
YOY-21.524-5.620-15.904
5Y-577.509-8.306-569.203
10Y-312.825-8.854-303.971
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Actinogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.27 means the investor is paying $4.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Actinogen Medical Ltd:

  • The EOD is 5.634. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.274. Based on the equity, the company is fair priced.
  • The TTM is 7.673. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.634MRQ4.274+1.360
MRQ4.274TTM7.673-3.399
TTM7.673YOY10.984-3.312
TTM7.6735Y8.296-0.624
5Y8.29610Y11.962-3.666
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.6341.858+3.776
MRQ4.2742.090+2.184
TTM7.6732.091+5.582
YOY10.9842.866+8.118
5Y8.2963.488+4.808
10Y11.9623.836+8.126
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Actinogen Medical Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Actinogen Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001-4%-0.001+49%0.000-77%0.000-630%
Book Value Per Share--0.0050.006-7%0.008-37%0.007-23%0.006-11%
Current Ratio--5.4236.503-17%11.325-52%14.337-62%11.386-52%
Debt To Asset Ratio--0.1540.130+18%0.082+88%0.079+96%0.065+137%
Debt To Equity Ratio--0.1820.146+25%0.088+108%0.086+113%0.071+158%
Dividend Per Share----0%-0%-0%-0%
Eps---0.005-0.002-52%-0.002-68%-0.001-77%-0.001-82%
Free Cash Flow Per Share---0.003-0.002-20%-0.001-50%-0.001-68%-0.001-77%
Free Cash Flow To Equity Per Share--0.001-0.001+168%-0.001+196%0.000+130%-0.001+141%
Gross Profit Margin--1.0001.525-34%1.278-22%1.142-12%1.123-11%
Intrinsic Value_10Y_max---0.070--------
Intrinsic Value_10Y_min---0.185--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.008--------
Intrinsic Value_3Y_max---0.013--------
Intrinsic Value_3Y_min---0.033--------
Intrinsic Value_5Y_max---0.025--------
Intrinsic Value_5Y_min---0.068--------
Market Cap67480678.144+24%51192238.592100833197.227-49%200173287.494-74%138035339.993-63%132377878.513-61%
Net Profit Margin----0.5690%-3.9580%-52.9680%-40.5530%
Operating Margin----0.9350%-4.4810%-41.2580%-37.7760%
Operating Ratio---1.271-100%4.752-100%3.292-100%9.802-100%
Pb Ratio5.634+24%4.2747.673-44%10.984-61%8.296-48%11.962-64%
Pe Ratio-1.460-32%-1.107-10.669+863%-17.614+1491%-20.282+1731%-35.559+3111%
Price Per Share0.029+24%0.0220.043-49%0.086-74%0.059-63%0.057-61%
Price To Free Cash Flow Ratio-2.598-32%-1.971-6.285+219%-21.524+992%-577.509+29199%-312.825+15771%
Price To Total Gains Ratio-47.230-32%-35.829-47.594+33%-2108.224+5784%-997776.701+2784694%-485233.732+1354187%
Quick Ratio--5.4036.457-16%11.292-52%9.641-44%8.796-39%
Return On Assets---0.816-0.381-53%-0.216-74%-0.187-77%-0.140-83%
Return On Equity---0.965-0.441-54%-0.233-76%-0.205-79%-0.153-84%
Total Gains Per Share---0.001-0.001-4%-0.001+49%0.000-77%0.000-630%
Usd Book Value--7728489.4888343053.241-7%12204460.611-37%9990594.884-23%8702811.550-11%
Usd Book Value Change Per Share--0.0000.000-4%-0.001+49%0.000-77%0.000-630%
Usd Book Value Per Share--0.0030.004-7%0.005-37%0.004-23%0.004-11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.002-52%-0.001-68%-0.001-77%-0.001-82%
Usd Free Cash Flow---4189282.310-3352505.869-20%-2079357.335-50%-1336651.739-68%-965438.039-77%
Usd Free Cash Flow Per Share---0.002-0.001-20%-0.001-50%-0.001-68%0.000-77%
Usd Free Cash Flow To Equity Per Share--0.001-0.001+168%-0.001+196%0.000+130%0.000+141%
Usd Market Cap43538533.539+24%33029232.34065057578.851-49%129151805.091-74%89060401.363-63%85410207.217-61%
Usd Price Per Share0.019+24%0.0140.028-49%0.056-74%0.038-63%0.037-61%
Usd Profit---7456356.387-3554407.230-52%-2695603.178-64%-2000783.469-73%-1377227.141-82%
Usd Revenue---1252924.848-100%830087.383-100%391125.249-100%314603.197-100%
Usd Total Gains Per Share--0.0000.000-4%-0.001+49%0.000-77%0.000-630%
 EOD+5 -3MRQTTM+6 -26YOY+10 -225Y+6 -2610Y+6 -26

4.2. Fundamental Score

Let's check the fundamental score of Actinogen Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.460
Price to Book Ratio (EOD)Between0-15.634
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.403
Current Ratio (MRQ)Greater than15.423
Debt to Asset Ratio (MRQ)Less than10.154
Debt to Equity Ratio (MRQ)Less than10.182
Return on Equity (MRQ)Greater than0.15-0.965
Return on Assets (MRQ)Greater than0.05-0.816
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Actinogen Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.531
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.029
OpenGreater thanClose0.031
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-12-31
Long-term Assets Other  -2,7020-2,702181-2,5200-2,5204,7702,250
Gross Profit  5023018031,1391,9421,7373,679-3,891-212



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets14,164
Total Liabilities2,186
Total Stockholder Equity11,978
 As reported
Total Liabilities 2,186
Total Stockholder Equity+ 11,978
Total Assets = 14,164

Assets

Total Assets14,164
Total Current Assets11,854
Long-term Assets2,310
Total Current Assets
Cash And Cash Equivalents 11,472
Net Receivables 338
Other Current Assets 44
Total Current Assets  (as reported)11,854
Total Current Assets  (calculated)11,854
+/-0
Long-term Assets
Property Plant Equipment 60
Long-term Assets Other 2,250
Long-term Assets  (as reported)2,310
Long-term Assets  (calculated)2,310
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,186
Long-term Liabilities0
Total Stockholder Equity11,978
Total Current Liabilities
Short-term Debt 45
Accounts payable 1,880
Other Current Liabilities 261
Total Current Liabilities  (as reported)2,186
Total Current Liabilities  (calculated)2,186
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock90,783
Retained Earnings -80,248
Accumulated Other Comprehensive Income 11,165
Other Stockholders Equity -9,721
Total Stockholder Equity (as reported)11,978
Total Stockholder Equity (calculated)11,978
+/-0
Other
Cash and Short Term Investments 11,472
Common Stock Shares Outstanding 2,307,310
Liabilities and Stockholders Equity 14,164
Net Debt -11,428
Net Working Capital 9,668
Short Long Term Debt Total 45



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-30
> Total Assets 
53
0
285
269
3,064
3,064
2,942
2,942
2,418
2,418
2,008
2,008
1,709
1,709
1,342
1,342
1,264
1,264
1,141
1,141
788
788
466
466
461
461
276
276
1,519
1,519
1,262
1,262
8,439
8,439
15,579
15,579
14,630
14,630
12,950
12,950
10,882
10,882
10,210
10,210
10,384
10,384
18,026
18,026
20,211
20,211
16,222
16,222
13,215
13,215
0
11,936
0
16,566
0
18,378
0
25,658
23,306
23,306
17,819
17,819
15,209
15,209
14,164
14,16415,20915,20917,81917,81923,30623,30625,658018,378016,566011,936013,21513,21516,22216,22220,21120,21118,02618,02610,38410,38410,21010,21010,88210,88212,95012,95014,63014,63015,57915,5798,4398,4391,2621,2621,5191,5192762764614614664667887881,1411,1411,2641,2641,3421,3421,7091,7092,0082,0082,4182,4182,9422,9423,0643,064269285053
   > Total Current Assets 
0
0
0
0
0
0
0
2,598
0
0
0
1,861
0
0
0
1,119
0
0
0
907
0
0
0
286
0
0
0
138
0
0
0
1,154
0
0
0
10,021
0
0
0
7,744
5,857
5,857
5,364
5,364
5,716
5,716
13,536
13,536
15,863
15,863
12,527
12,527
9,243
9,243
8,164
8,164
13,022
13,022
15,056
15,056
22,571
22,571
20,417
20,417
15,117
15,117
12,688
12,688
11,854
11,85412,68812,68815,11715,11720,41720,41722,57122,57115,05615,05613,02213,0228,1648,1649,2439,24312,52712,52715,86315,86313,53613,5365,7165,7165,3645,3645,8575,8577,74400010,0210001,1540001380002860009070001,1190001,8610002,5980000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
2,541
0
0
0
1,850
0
0
0
1,085
0
0
0
861
0
0
0
204
0
0
0
113
0
0
0
1,128
0
0
0
9,806
0
0
0
752
2,598
2,598
1,895
1,895
4,420
4,420
10,004
10,004
15,468
15,468
7,637
7,637
8,458
8,458
0
5,040
0
2,065
0
13,422
0
7,100
16,370
16,370
14,484
14,484
8,460
8,460
11,472
11,4728,4608,46014,48414,48416,37016,3707,100013,42202,06505,04008,4588,4587,6377,63715,46815,46810,00410,0044,4204,4201,8951,8952,5982,5987520009,8060001,1280001130002040008610001,0850001,8500002,5410000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,026
3,077
3,077
2,095
2,095
1,091
1,091
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,0911,0912,0952,0953,0773,0774,026000000000000000000000000000000000000000
       Net Receivables 
2
0
0
50
52
52
54
54
16
16
10
10
61
61
32
33
51
51
31
30
375
375
23
23
13
13
4
4
46
46
11
11
526
526
182
182
1,368
1,368
2,929
2,929
38
38
1,342
1,342
198
198
3,485
3,485
378
378
4,833
4,833
762
762
2,662
2,662
85
85
1,544
1,634
307
307
4,047
3,942
582
582
4,124
4,124
338
3384,1244,1245825823,9424,0473073071,6341,54485852,6622,6627627624,8334,8333783783,4853,4851981981,3421,34238382,9292,9291,3681,3681821825265261111464644131323233753753031515133326161101016165454525250002
       Other Current Assets 
0
0
33
165
0
0
3
3
0
0
1
1
0
0
2
2
0
0
15
15
0
0
59
59
0
0
21
21
4
4
15
15
6
6
34
34
6
6
38
38
7
7
33
33
8
8
47
47
0
0
0
57
0
0
401
461
0
0
0
0
0
0
0
105
0
51
0
105
44
441050510105000000046140100570004747883333773838663434661515442121005959001515002200110033001653300
   > Long-term Assets 
0
0
0
0
0
0
0
343
0
0
0
147
0
0
0
223
0
0
0
234
0
0
0
180
0
0
0
138
0
0
0
108
0
0
0
5,558
0
0
0
5,205
0
0
0
4,846
0
0
0
4,490
0
0
0
3,695
0
0
0
3,772
0
0
0
3,322
0
0
2,889
2,889
2,702
2,702
2,520
2,520
2,310
2,3102,5202,5202,7022,7022,8892,889003,3220003,7720003,6950004,4900004,8460005,2050005,5580001080001380001800002340002230001470003430000000
       Property Plant Equipment 
7
0
6
6
5
5
13
13
109
109
106
106
101
101
148
148
140
140
144
144
145
145
137
137
130
130
121
120
114
114
107
107
98
98
7
7
14
14
8
8
5
5
2
2
1
1
0
0
0
0
0
0
435
435
391
391
340
340
254
254
210
210
169
169
138
138
113
113
60
601131131381381691692102102542543403403913914354350000001122558814147798981071071141141201211301301371371451451441441401401481481011011061061091091313556607
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
0
0
0
0
5,757
5,757
5,551
5,551
5,373
5,373
5,197
5,197
5,020
5,020
4,844
4,843
4,667
4,667
4,490
4,490
4,313
4,313
3,660
3,660
3,502
3,502
0
3,346
0
3,169
0
3,033
0
2,877
2,720
2,720
2,564
2,564
2,408
2,408
0
02,4082,4082,5642,5642,7202,7202,87703,03303,16903,34603,5023,5023,6603,6604,3134,3134,4904,4904,6674,6674,8434,8445,0205,0205,1975,1975,3735,3735,5515,5515,7575,75700001616161616161616161616161616161616160000000000
       Other Assets 
0
0
7
0
5
5
330
330
65
65
41
41
96
96
76
76
131
131
90
90
61
61
43
43
21
21
18
18
2
2
2
2
5,757
5,757
5,551
5,551
5,373
5,373
5,197
5,197
5,020
5,020
4,844
4,844
4,667
4,667
4,490
4,490
35
35
35
35
35
35
35
35
35
35
35
35
0
0
0
0
0
0
0
0
0
0000000003535353535353535353535354,4904,4904,6674,6674,8444,8445,0205,0205,1975,1975,3735,3735,5515,5515,7575,7572222181821214343616190901311317676969641416565330330550700
> Total Liabilities 
29
0
27
60
102
102
82
82
174
174
105
105
242
242
174
174
207
207
95
95
94
94
119
119
112
112
81
81
48
48
50
50
97
97
223
223
191
191
824
824
604
604
844
844
1,047
1,047
768
768
2,001
2,001
557
557
1,139
1,139
0
1,048
0
1,104
0
920
0
1,082
1,566
1,566
1,708
1,746
1,802
1,802
2,186
2,1861,8021,8021,7461,7081,5661,5661,082092001,10401,04801,1391,1395575572,0012,0017687681,0471,04784484460460482482419119122322397975050484881811121121191199494959520720717417424224210510517417482821021026027029
   > Total Current Liabilities 
29
0
27
60
102
102
82
82
174
174
105
105
242
242
174
174
207
207
95
95
94
94
119
119
112
112
81
81
48
48
50
50
97
97
223
223
191
191
824
824
604
604
844
844
1,047
1,047
768
768
2,001
2,001
557
557
809
809
744
744
847
847
755
755
956
956
1,480
1,480
1,708
1,708
1,802
1,802
2,186
2,1861,8021,8021,7081,7081,4801,4809569567557558478477447448098095575572,0012,0017687681,0471,04784484460460482482419119122322397975050484881811121121191199494959520720717417424224210510517417482821021026027029
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,026
0
0
0
2,095
0
0
0
0
0
0
0
0
0
0
0
86
0
0
0
71
0
0
78
78
0
89
0
87
45
458708907878007100086000000000002,0950004,026000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
36
36
11
11
174
174
14
14
239
239
23
23
206
206
29
29
90
90
9
9
112
112
10
10
12
12
9
9
55
55
192
192
113
113
690
690
140
140
649
649
685
685
507
507
1,780
1,780
283
283
423
423
47
47
67
67
392
392
364
364
899
1,308
375
375
1,101
1,101
1,880
1,8801,1011,1013753751,308899364364392392676747474234232832831,7801,78050750768568564964914014069069011311319219255559912121010112112999090292920620623232392391414174174111136360000
       Other Current Liabilities 
29
0
27
39
6
6
72
72
0
0
92
91
3
3
151
151
1
1
66
66
3
3
110
110
0
0
71
71
36
36
41
41
41
41
31
30
78
78
135
134
464
464
195
195
361
361
89
261
75
75
183
275
84
84
584
611
457
457
0
292
0
0
502
93
1,333
1,244
700
613
261
2616137001,2441,3339350200292045745761158484842751837575261893613611951954644641341357878303141414141363671710011011033666611151151339192007272663927029
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
304
0
0
0
165
0
0
87
87
0
38
0
0
0
0003808787001650003040000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
330
0
304
0
257
0
165
0
127
0
87
0
38
0
0
0
000380870127016502570304033000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
24
24
258
208
2,962
2,962
2,859
2,859
2,244
2,244
1,902
1,902
1,468
1,468
1,168
1,168
1,057
1,057
1,046
1,046
695
695
347
347
348
348
194
194
1,471
1,471
1,212
1,212
8,342
8,342
15,357
15,357
14,439
14,439
12,125
12,125
10,279
10,279
9,366
9,366
9,337
9,337
17,258
17,258
18,211
18,211
15,665
15,665
12,076
12,076
0
10,889
0
15,462
0
17,458
0
24,576
21,740
21,740
17,425
16,073
14,961
13,407
11,978
11,97813,40714,96116,07317,42521,74021,74024,576017,458015,462010,889012,07612,07615,66515,66518,21118,21117,25817,2589,3379,3379,3669,36610,27910,27912,12512,12514,43914,43915,35715,3578,3428,3421,2121,2121,4711,4711941943483483473476956951,0461,0461,0571,0571,1681,1681,4681,4681,9021,9022,2442,2442,8592,8592,9622,9622082582424
   Retained Earnings -80,248-68,692-68,692-65,378-65,378-57,939-57,939-54,237-54,237-48,442-48,442-46,884-46,884-44,527-44,527-43,237-43,237-39,196-39,196-36,441-36,441-29,309-29,309-26,704-26,704-23,078-23,078-21,738-21,738-19,888000-16,254000-10,823000-10,383000-10,218000-8,689000-7,947000-7,209000-6,2820000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
4,819
0
0
0
4,789
0
0
0
4,792
0
0
0
4,815
0
0
0
4,789
0
0
0
4,789
0
0
0
4,789
0
0
0
5,356
0
0
0
5,705
0
0
0
5,865
0
0
0
6,128
0
0
0
6,816
0
0
0
7,491
0
0
0
5,846
0
0
2,736
9,068
0
9,937
0
10,585
11,165
11,16510,58509,93709,0682,736005,8460007,4910006,8160006,1280005,8650005,7050005,3560004,7890004,7890004,7890004,8150004,7920004,7890004,8190000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,888
Cost of Revenue-406
Gross Profit4,4824,482
 
Operating Income (+$)
Gross Profit4,482
Operating Expense-15,467
Operating Income-15,873-10,985
 
Operating Expense (+$)
Research Development8,900
Selling General Administrative1,794
Selling And Marketing Expenses4,774
Operating Expense15,46715,467
 
Net Interest Income (+$)
Interest Income367
Interest Expense-17
Other Finance Cost-0
Net Interest Income350
 
Pretax Income (+$)
Operating Income-15,873
Net Interest Income350
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,640-16,106
EBIT - interestExpense = -15,890
-15,640
-10,736
Interest Expense17
Earnings Before Interest and Taxes (EBIT)-15,873-15,624
Earnings Before Interest and Taxes (EBITDA)-15,467
 
After tax Income (+$)
Income Before Tax-15,640
Tax Provision-0
Net Income From Continuing Ops-10,752-15,640
Net Income-10,752
Net Income Applicable To Common Shares-10,752
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,873
Total Other Income/Expenses Net233-350
 

Technical Analysis of Actinogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Actinogen. The general trend of Actinogen is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Actinogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Actinogen Medical Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.033 < 0.039 < 0.056.

The bearish price targets are: 0.028 > 0.027 > 0.027.

Tweet this
Actinogen Medical Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Actinogen Medical Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Actinogen Medical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Actinogen Medical Ltd. The current macd is -0.00052233.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Actinogen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Actinogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Actinogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Actinogen Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartActinogen Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Actinogen Medical Ltd. The current adx is 13.53.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Actinogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Actinogen Medical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Actinogen Medical Ltd. The current sar is 0.02836989.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Actinogen Medical Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Actinogen Medical Ltd. The current rsi is 46.53. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Actinogen Medical Ltd Daily Relative Strength Index (RSI) ChartActinogen Medical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Actinogen Medical Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Actinogen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Actinogen Medical Ltd Daily Stochastic Oscillator ChartActinogen Medical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Actinogen Medical Ltd. The current cci is -20.57998129.

Actinogen Medical Ltd Daily Commodity Channel Index (CCI) ChartActinogen Medical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Actinogen Medical Ltd. The current cmo is -8.47758472.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Actinogen Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartActinogen Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Actinogen Medical Ltd. The current willr is -90.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Actinogen Medical Ltd Daily Williams %R ChartActinogen Medical Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Actinogen Medical Ltd.

Actinogen Medical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Actinogen Medical Ltd. The current atr is 0.00275567.

Actinogen Medical Ltd Daily Average True Range (ATR) ChartActinogen Medical Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Actinogen Medical Ltd. The current obv is -25,269,921.

Actinogen Medical Ltd Daily On-Balance Volume (OBV) ChartActinogen Medical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Actinogen Medical Ltd. The current mfi is 70.14.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Actinogen Medical Ltd Daily Money Flow Index (MFI) ChartActinogen Medical Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Actinogen Medical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Actinogen Medical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Actinogen Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.531
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.029
OpenGreater thanClose0.031
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Actinogen with someone you think should read this too:
  • Are you bullish or bearish on Actinogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Actinogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Actinogen Medical Ltd

I send you an email if I find something interesting about Actinogen Medical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Actinogen Medical Ltd.

Receive notifications about Actinogen Medical Ltd in your mailbox!